Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Bulletin du Cancer is Scopus-indexed (Q3, CiteScore 1.6), WoS SCIE. Published by John Libbey.
Checked against the index lists dated .
ISSN 0007-4551Verify ISSN ↗1769-6917Verify ISSN ↗
Publisher: John Libbey
Cost to publish: About US$1,790 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Radiology, Nuclear Medicine and Imaging | 246 / 361 | 31st | Q3 |
| Hematology | 104 / 151 | 31st | Q3 |
| Oncology | 304 / 428 | 29th | Q3 |
| Cancer Research | 195 / 233 | 16th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 1966–present, best quartile Q3, CiteScore 1.6.
Bulletin du Cancer is Q3 in Radiology, Nuclear Medicine and Imaging (rank 246 of 361), Q3 in Hematology (rank 104 of 151) and Q3 in Oncology (rank 304 of 428), by CiteScore 2025. It is ranked in 4 subject areas in all.
Bulletin du Cancer is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.6, which places it in quartile Q3 at the 31st percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.280, quartile Q3, with an H-index of 46.
The publisher lists an article processing charge of about US$1,790 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Bulletin du Cancer is published by John Libbey. Its print ISSN is 0007-4551 and its online ISSN is 1769-6917.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Bulletin du Cancer has an h-index of 39 and a 2-year mean of 0.44 citations per paper (OpenAlex). Its Scopus CiteScore is 1.6, quartile Q3. On 2-year citations it ranks #273 of 346 Scopus journals in Radiology, Nuclear Medicine and Imaging.
Bulletin du Cancer published 267 papers in 2025; its busiest recent year was 2021 with 272. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 83 research articles (2026), authors are most often from France (77.5%), China (3.6%) and Belgium (3.2%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (0.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.